Back to search
FDAFDA · Food and drugs·Recall number D-1043-2020

Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1.6 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5553-3

Published March 25, 2020 · Recall initiated: March 2, 2020

Summary

FDA records drug Class II recall D-1043-2020, published March 25, 2020 and initiated March 2, 2020. Recalling firm: Noven Therapeutics, LLC; Status: Terminated; Reported quantity: 13761 boxes; Lot: Lot#: 85942, Exp 03/2020; 86281, Exp 06/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Out of specification for mechanical peel and shear.

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Therapeutics, LLC
Distributor
U.S.A. Nationwide
Lot
Lot#: 85942, Exp 03/2020; 86281, Exp 06/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1.6 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5553-3 recalled?

Yes. FDA published recall D-1043-2020 on March 25, 2020. Reported hazard: Defective Delivery System: Out of specification for mechanical peel and shear.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.